Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest stories Story 30 Oct 2025 Bridging the communication gap in Myasthenia Gravis: insights from the ENGAGE program Read More Story 29 Oct 2025 Closing the care gap: Optimizing post-fracture care in osteoporosis through FAN Read More Story 24 Oct 2025 Multidisciplinary collaboration as the future of patient-centered care Read More Latest press releases The press releases are intended for media and financial analysts Press release 29 Oct 2025 UCB to unveil new data for RYSTIGGO[®▼]and ZILBRYSQ[®▼] for gMG at the 2025 AANEM Annual Meeting and... Read More Press release 25 Oct 2025 BIMZELX[®] (bimekizumab-bkzx) three year rheumatology data at ACR 2025 demonstrated sustained... Read More Press release 14 Oct 2025 Final analysis of open-label extension (OLE) study of Fintepla[®]▼ (fenfluramine) in Lennox-Gastaut... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Story 30 Oct 2025 Bridging the communication gap in Myasthenia Gravis: insights from the ENGAGE program Read More
Story 29 Oct 2025 Closing the care gap: Optimizing post-fracture care in osteoporosis through FAN Read More
Press release 29 Oct 2025 UCB to unveil new data for RYSTIGGO[®▼]and ZILBRYSQ[®▼] for gMG at the 2025 AANEM Annual Meeting and... Read More
Press release 25 Oct 2025 BIMZELX[®] (bimekizumab-bkzx) three year rheumatology data at ACR 2025 demonstrated sustained... Read More
Press release 14 Oct 2025 Final analysis of open-label extension (OLE) study of Fintepla[®]▼ (fenfluramine) in Lennox-Gastaut... Read More
